Comments
Loading...

Actuate Therapeutics

ACTUNASDAQ
Logo brought to you by Benzinga Data
$8.00
-0.02-0.25%
At Close: -
$8.18
0.182.25%
After Hours: Sep 12, 7:47 AM EDT
15 minutes delayed

Actuate Therapeutics (NASDAQ:ACTU) Stock Quotes, Forecast and News Summary

Actuate Therapeutics Stock (NASDAQ: ACTU) stock price, news, charts, stock research, profile.

Open$8.02
Close$8.00
Volume / Avg.11.72K / 42.63K
Day Range$8.00 - $8.23
52 Wk Range7.33 - 10.16
Market Cap$156.33M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
43
Short Interest-
Days to Cover1

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
About Actuate Therapeutics Inc.
Sector
Health Care
Industry
Biotechnology
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapi...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ACTU
MOLN

FAQ

Q

How do I buy Actuate Therapeutics (ACTU) stock?

A

You can purchase shares of Actuate Therapeutics (NASDAQ:ACTU) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Actuate Therapeutics (ACTU) competitors?

Q

What is the forecast, or price target, for Actuate Therapeutics (ACTU) stock?

A

There is no analysis for Actuate Therapeutics to provide a consensus price target.

Q

What is the current price for Actuate Therapeutics (ACTU)?

A

The stock price for Actuate Therapeutics (NASDAQ: ACTU) is $8 last updated September 18, 2024 at 4:00 PM EDT.

Q

Does Actuate Therapeutics (ACTU) pay a dividend?

A

There are no upcoming dividends for Actuate Therapeutics.

Q

When is Actuate Therapeutics (NASDAQ:ACTU) reporting earnings?

A

Actuate Therapeutics’s Q3 earnings are confirmed for Thursday, November 21, 2024.

Q

Is Actuate Therapeutics (ACTU) going to split?

A

There is no upcoming split for Actuate Therapeutics.

Q

What sector and industry does Actuate Therapeutics (ACTU) operate in?

A

Actuate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch